BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37869101)

  • 1. Healthcare access dimensions and uterine cancer survival: a national cancer database study.
    Anastasio MK; Gupta A; Akinyemiju TF; Previs RA
    Front Oncol; 2023; 13():1263371. PubMed ID: 37869101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study.
    Montes de Oca MK; Wilson LE; Previs RA; Gupta A; Joshi A; Huang B; Pisu M; Liang M; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
    J Natl Compr Canc Netw; 2022 Nov; 20(11):1255-1266.e11. PubMed ID: 36351338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
    Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
    Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer.
    Kucera CW; Tian C; Tarney CM; Presti C; Jokajtys S; Winkler SS; Casablanca Y; Bateman NW; Mhawech-Fauceglia P; Wenzel L; Hamilton CA; Chan JK; Jones NL; Rocconi RP; O'Connor TD; Farley JH; Shriver CD; Conrads TP; Phippen NT; Maxwell GL; Darcy KM
    JAMA Netw Open; 2023 Apr; 6(4):e238437. PubMed ID: 37067801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in outcomes for high-grade uterine cancer: A California cancer registry study.
    Baskovic M; Lichtensztajn DY; Nguyen T; Karam A; English DP
    Cancer Med; 2018 Sep; 7(9):4485-4495. PubMed ID: 30123978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-care access dimensions and ovarian cancer survival: SEER-Medicare analysis of the ORCHiD study.
    Montes de Oca MK; Chen Q; Howell E; Wilson LE; Meernik C; Previs RA; Huang B; Pisu M; Liang MI; Ward KC; Schymura MJ; Berchuck A; Akinyemiju T
    JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 36794910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian Cancer.
    Akinyemiju TF; Wilson LE; Diaz N; Gupta A; Huang B; Pisu M; Deveaux A; Liang M; Previs RA; Moss HA; Joshi A; Ward KC; Schymura MJ; Berchuck A; Potosky AL
    Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1383-1393. PubMed ID: 35477150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in outcome for patients with cholangiocarcinoma: Racial/ethnic disparity or socioeconomic factors?
    Lee RM; Liu Y; Gamboa AC; Staley CA; Kooby D; Russell MC; Cardona K; Maithel SK
    Surg Oncol; 2020 Sep; 34():126-133. PubMed ID: 32891317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities at the Intersection of Race and Ethnicity: Examining Trends and Outcomes in Hispanic Women With Breast Cancer.
    Champion CD; Thomas SM; Plichta JK; Parrilla Castellar E; Rosenberger LH; Greenup RA; Hyslop T; Hwang ES; Fayanju OM
    JCO Oncol Pract; 2022 May; 18(5):e827-e838. PubMed ID: 33026950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.
    Shah NN; Xi Y; Liu Y; Koff JL; Flowers CR; Behera M; Cohen JB
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e312-e320. PubMed ID: 31029647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study.
    Vassantachart A; Marietta M; Mehta S; Lin E; Bian SX
    J Gastrointest Oncol; 2022 Dec; 13(6):2922-2937. PubMed ID: 36636091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
    Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
    Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial Differences in Survival Among Advanced-stage Non-small-Cell Lung Cancer Patients Who Received Immunotherapy: An Analysis of the US National Cancer Database (NCDB).
    Gupta A; Zhang D; Braithwaite D; Karanth SD; Tailor TD; Clarke JM; Akinyemiju T
    J Immunother; 2022 Feb-Mar 01; 45(2):132-137. PubMed ID: 34747372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
    Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
    JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of area-level socioeconomic status and non-small cell lung cancer stage by race/ethnicity and health care-level factors: Analysis of the National Cancer Database.
    Gupta A; Omeogu CH; Islam JY; Joshi AR; Akinyemiju TF
    Cancer; 2022 Aug; 128(16):3099-3108. PubMed ID: 35719098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial/Ethnic Disparities in All-Cause Mortality among Patients Diagnosed with Triple-Negative Breast Cancer.
    Wang F; Zheng W; Bailey CE; Mayer IA; Pietenpol JA; Shu XO
    Cancer Res; 2021 Feb; 81(4):1163-1170. PubMed ID: 33272926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian Cancer Epidemiology, Healthcare Access and Disparities (ORCHiD): methodology for a population-based study of black, Hispanic and white patients with ovarian cancer.
    Akinyemiju T; Deveaux A; Wilson L; Gupta A; Joshi A; Bevel M; Omeogu C; Ohamadike O; Huang B; Pisu M; Liang M; McFatrich M; Daniell E; Fish LJ; Ward K; Schymura M; Berchuck A; Potosky AL
    BMJ Open; 2021 Oct; 11(10):e052808. PubMed ID: 34607872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Black race independently predicts worse survival in uterine carcinosarcoma.
    Erickson BK; Doo DW; Zhang B; Huh WK; Leath CA
    Gynecol Oncol; 2014 May; 133(2):238-41. PubMed ID: 24613675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist Consultation.
    Gupta A; Chen Q; Wilson LE; Huang B; Pisu M; Liang M; Previs RA; Moss HA; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
    JAMA Netw Open; 2023 Feb; 6(2):e2254595. PubMed ID: 36723938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database.
    Fedewa SA; Lerro C; Chase D; Ward EM
    Gynecol Oncol; 2011 Jul; 122(1):63-8. PubMed ID: 21463888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.